BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17114455)

  • 1. IFN-beta-mediated up-regulation of CD1d in bacteria-infected APCs.
    Raghuraman G; Geng Y; Wang CR
    J Immunol; 2006 Dec; 177(11):7841-8. PubMed ID: 17114455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay of cytokines and microbial signals in regulation of CD1d expression and NKT cell activation.
    Sköld M; Xiong X; Illarionov PA; Besra GS; Behar SM
    J Immunol; 2005 Sep; 175(6):3584-93. PubMed ID: 16148102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted expression of human CD1d in transgenic mice reveals independent roles for thymocytes and thymic APCs in positive and negative selection of Valpha14i NKT cells.
    Schümann J; Pittoni P; Tonti E; Macdonald HR; Dellabona P; Casorati G
    J Immunol; 2005 Dec; 175(11):7303-10. PubMed ID: 16301636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of CD1d-restricted NK T lymphocytes in the immune response to oral infection with Salmonella typhimurium.
    Berntman E; Rolf J; Johansson C; Anderson P; Cardell SL
    Eur J Immunol; 2005 Jul; 35(7):2100-9. PubMed ID: 15940666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of CD1d expression by murine tumor cells: escape from immunosurveillance or alternate target molecules?
    Fiedler T; Walter W; Reichert TE; Maeurer MJ
    Int J Cancer; 2002 Mar; 98(3):389-97. PubMed ID: 11920590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invariant V alpha 14+ NKT cells participate in the early response to enteric Listeria monocytogenes infection.
    Ranson T; Bregenholt S; Lehuen A; Gaillot O; Leite-de-Moraes MC; Herbelin A; Berche P; Di Santo JP
    J Immunol; 2005 Jul; 175(2):1137-44. PubMed ID: 16002715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injury-induced suppression of effector T cell immunity requires CD1d-positive APCs and CD1d-restricted NKT cells.
    Palmer JL; Tulley JM; Kovacs EJ; Gamelli RL; Taniguchi M; Faunce DE
    J Immunol; 2006 Jul; 177(1):92-9. PubMed ID: 16785503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo.
    Ilyinskii PO; Wang R; Balk SP; Exley MA
    J Virol; 2006 Jul; 80(14):7146-58. PubMed ID: 16809320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral danger signals control CD1d de novo synthesis and NKT cell activation.
    Raftery MJ; Winau F; Giese T; Kaufmann SH; Schaible UE; Schönrich G
    Eur J Immunol; 2008 Mar; 38(3):668-79. PubMed ID: 18253929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human NKT cells express granulysin and exhibit antimycobacterial activity.
    Gansert JL; Kiessler V; Engele M; Wittke F; Röllinghoff M; Krensky AM; Porcelli SA; Modlin RL; Stenger S
    J Immunol; 2003 Mar; 170(6):3154-61. PubMed ID: 12626573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD1d under the control of a MHC class Ia promoter skews the development of NKT cells, but not CD8+ T cells.
    Xu H; Chun T; Colmone A; Nguyen H; Wang CR
    J Immunol; 2003 Oct; 171(8):4105-12. PubMed ID: 14530332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
    Sköld M; Faizunnessa NN; Wang CR; Cardell S
    J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice.
    Falcone M; Facciotti F; Ghidoli N; Monti P; Olivieri S; Zaccagnino L; Bonifacio E; Casorati G; Sanvito F; Sarvetnick N
    J Immunol; 2004 May; 172(10):5908-16. PubMed ID: 15128771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interdependency of MHC class II/self-peptide and CD1d/self-glycolipid presentation by TNF-matured dendritic cells for protection from autoimmunity.
    Wiethe C; Schiemann M; Busch D; Haeberle L; Kopf M; Schuler G; Lutz MB
    J Immunol; 2007 Apr; 178(8):4908-16. PubMed ID: 17404272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance.
    Faunce DE; Stein-Streilein J
    J Immunol; 2002 Jul; 169(1):31-8. PubMed ID: 12077225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent tolerance.
    Sonoda KH; Stein-Streilein J
    Eur J Immunol; 2002 Mar; 32(3):848-57. PubMed ID: 11870629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cell-type specific CD1d expression program modulates invariant NKT cell development and function.
    Zimmer MI; Colmone A; Felio K; Xu H; Ma A; Wang CR
    J Immunol; 2006 Feb; 176(3):1421-30. PubMed ID: 16424169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD1d-independent NKT cells in beta 2-microglobulin-deficient mice have hybrid phenotype and function of NK and T cells.
    Maeda M; Shadeo A; MacFadyen AM; Takei F
    J Immunol; 2004 May; 172(10):6115-22. PubMed ID: 15128797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.